You just read:

Nektar Therapeutics Announces Positive Topline Results for NKTR-102 From First Stage of Phase 2 Study in Platinum-Resistant Ovarian Cancer

News provided by

Nektar Therapeutics

Jan 12, 2010, 09:00 ET